Gül Başaran
- Oncology top 5%
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 10
- Colorectal Cancer Treatments and Studies 5
- Vascular Tumors and Angiosarcomas 4
- Cancer Research top 10%
- Breast Cancer Treatment Studies 12
- Statistics and Probability top 5%
-
- Advanced Breast Cancer Therapies 8
- Gastric Cancer Management and Outcomes 4
- Emergency Medical Services top 10%
-
- Economic and Financial Impacts of Cancer 5
- Co-authors
- Martine PiccartPerran Fulden YumukFaysal DaneGeorge W. SledgePatrick TherasseLaura BiganzoliHans‐Joachim LückStephen Chan
- Partner nations
- TürkiyeBelgiumUnited Kingdom
In The Last Decade
Gül Başaran
44 papers receiving 918 citations
Peers
Comparison fields: 5 of 76
- Oncology 605
- Cancer Research 302
- Statistics and Probability 81
- Pulmonary and Respiratory Medicine 249
- Emergency Medical Services 42
Countries citing papers authored by Gül Başaran
This map shows the geographic impact of Gül Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gül Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gül Başaran more than expected).
Fields of papers citing papers by Gül Başaran
This network shows the impact of papers produced by Gül Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gül Başaran. The network helps show where Gül Başaran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gül Başaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 6 | |
| 8 | 2017 | 26 | |
| 9 | 2014 | 10 | |
| 10 | 2014 | 5 | |
| 11 | 2013 | 6 | |
| 12 | 2012 | 11 | |
| 13 | TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA. | 2011 | 2 |
| 14 | 2010 | 21 | |
| 15 | 2010 | 19 | |
| 16 | 2009 | 46 | |
| 17 | 2009 | 42 | |
| 18 | 2008 | 164 | |
| 19 | 2007 | 11 | |
| 20 | 2004 | 3 |
About Gül Başaran
Gül Başaran is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 50 papers that have together received 952 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers), Advanced Breast Cancer Therapies (8 papers), Economic and Financial Impacts of Cancer (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (605 citations), Cancer Research (302 citations) and Statistics and Probability (81 citations). Gül Başaran has collaborated with scholars based in Türkiye, Belgium and United Kingdom. Frequent co-authors include Martine Piccart, Perran Fulden Yumuk, Faysal Dane, George W. Sledge, Patrick Therasse, Laura Biganzoli, Hans‐Joachim Lück, Stephen Chan, M. Bontenbal and Robert Paridaens. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, ESMO Open, The Breast and Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.